Announced Fri, 19 Jun · 13:04 IST
Promoter Edoras files annual declaration confirming no new share encumbrances
Ownership Changes View source PDF
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹725.00
prior close
₹735.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2-0.1-0.1+0.1-4.1-6.2-8.3-9.2-6.9-10.7-13.0——
Up moveDown movePending
AI summary
Edoras Investment Holdings Pte. Ltd., a promoter of Nephrocare Health Services (NEPHROPLUS), filed its annual declaration under Regulation 31(4) of the SEBI Takeover Regulations for FY ending March 31, 2026. The declaration confirms that no new encumbrance was created on shares of the company during the financial year, other than those already disclosed. This is a routine yearly compliance filing by the promoter.
Likely market impact
Routine compliance filing. No new pledges or encumbrances on promoter-held shares during FY26. Neutral for shareholders.